Why the study?
Does implantation of an automatic cardioverter-defibrillator in conjunction with endocardial resection prevent recurrent ventricular tachyarrhythmias or sudden death in patients with drug-refractory ventricular arrhythmias and prior myocardial infarction?
Population
28 patients with drug-refractory ventricular arrhythmias, all of whom had previous myocardial infarctions…
Design
Case_series
Follow-up
8 to 51 months (mean, 25)
Authors
Loading...
May support combined device-resection protection in refractory post-MI VT; hypothesis-generating and leaves open need for controlled trials.
Does implantation of an automatic cardioverter-defibrillator in conjunction with endocardial resection prevent recurrent ventricular tachyarrhythmias or sudden death in patients with drug-refractory ventricular arrhythmias and prior myocardial infarction?
Implantation of an automatic cardioverter-defibrillator during endocardial resection provides effective protection against recurrent ventricular tachyarrhythmias and sudden death in high-risk patients.
Platia et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: